Antiseptic And Disinfectant Market Size, Share & Trends Analysis Report By Type (Quaternary Ammonium Compounds), By Product (Enzymatic Cleaners), By End-use, By Sales Channel, By Region, And Segment Forecasts, 2023 - 2030

Report Overview

The global antiseptic and disinfectant market size was valued at USD 29.15 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 10.49% from 2023 to 2030. Increase in prevalence of diseases such as typhoid, cholera, hepatitis A, food poisoning, and dengue, primarily due to lack of home cleanliness, is one of the major factors expected to drive antiseptics & disinfectants market growth. For instance, as per a report published by WHO in 2022, Over the last two decades, the number of dengue cases reported to WHO has surged by more than 8 fold, from 505,430 cases in 2000 to over 2.4 million in 2010, and 5.2 million in 2019. Such diseases are mainly caused by viruses, bacteria, & germs, which thrive in unhealthy home environments and unhygienic toilets, latrines, & kitchens.

The application of antiseptic and disinfectant solutions is, therefore, an essential requirement to maintain home cleanliness. Such solutions prevent growth of harmful bacteria and viruses, reducing the chance of acquiring these diseases. Hence, increase in awareness about home cleanliness is anticipated to propel the market over the forecast period.

The current COVID-19 outbreak is expected to have a substantial impact on the antiseptics and disinfectants market. The COVID-19 pandemic, as well as an overall increase in hospital admissions around the world, has boosted demand for medical disposables. To meet rising worldwide demand such as long used for cleaning, deodorizing and disinfecting power in high-traffic facilities, including office buildings, hotels, schools, nursing homes and hospitals due to COVID-19 outbreak, the WHO has urged industry and governments to expand production of antiseptics and disinfectants. For instance, according to German Federal Statistical Office in 2020, demand for disinfectants has risen in the aftermath of the coronavirus pandemic, for example, 80% more hygiene products were produced in Germany between January and September 2020 than in the same period last year.

Additionally, antiseptics and disinfectants manufacturing companies use unique and new technologies to design, produce, and sell products to diverse end customers based on the amount of protection required for distinct job risks. For instance, in November 2020the Environmental Protection Agency (EPA) of the U.S has approved 3M's disinfectant TB Quat for SARS-CoV-2 which is a ready-to-use cleaner. Third-party lab testing of 3M's disinfectant TB Quat ready-to-use cleaner on hard, non-porous surfaces with a 60-second contact period proved the disinfectant's effectiveness against the virus. As a result, market growth is expected to accelerate in the near future.

 Moreover, in January 2021, 5 SC Johnson home cleaning products have been added to Health Canada's list of effective disinfectants for use against SARS-CoV-2. SC Johnson has approved the following disinfectants to kill SARS-CoV-2, the virus that causes COVID-19 symptoms like scrubbing bubbles. They come in a variety of fragrances. Thus, due to the past and ongoing advancements through various companies, positive impact of the COVID-19 pandemic was seen on the market.

 Increasing incidence of HAIs due to lack of precaution and sanitation is one of the leading factors contributing to market growth. For instance, as per the Healthcare-Associated Infections in 2020, every year, around one in every 25 hospital patients acquires at least one HAI. Antiseptics and disinfectants offer general anti-contamination protection and can help reduce the incidence of HAIs. They can also keep bacterial and other microbial diseases from entering the body of a patient. Over the forecast period, these factors are expected to drive market expansion.

 Gastrointestinal (GI) endoscopy allows doctors to view the inner lining of digestive tract. The endoscope can enable diagnosis and treatment of several GI diseases. A GI endoscopy can be performed either in inpatient or outpatient settings. However, it can lead to several complications if the endoscopes are not properly reprocessed. To reduce the danger of spreading environmental or patient-borne pathogens between patients, endoscopes must be reprocessed according to infection-control protocols. In such cases, application of proper disinfectant and antiseptics solutions is essential to prevent transmission of infections.

 Moreover, increasing demand for endoscopy is expected to increase the risk of getting HAIs. For instance, as per BMJ Publishing Group Ltd. & British Society of Gastroenterology in 2018, the need for gastrointestinal endoscopy for colon cancer screening in symptomatic patients has skyrocketed. Over the last five years, demand in several UK cities has virtually doubled. Therefore, increasing use of endoscope reprocesses and surgical units is expected to propel the market over the forecast period.

 Growing number of surgeries globally is also a key factor expected to drive the market growth over the forecast period. For instance, as per the Mölnlycke Health Care AB, 70.00 million surgical procedures are performed every year in Europe. Similarly, according to the Healthcare Cost and Utilization Project (HCUP), in 2018, more than 9,942,000 surgeries were performed in the U.S. within ambulatory care settings. In case of surgeries, the use of antiseptics & disinfectant products is one of the essential requirement in hospitals, clinics, and ambulatory surgery centers. Therefore, such instances are expected to drive the antiseptics & disinfectants market growth.

Type Insights

Based on type, quaternary ammonium compounds segment held the largest market in 2022 with around 31.4% and is expected to witness considerable growth over the forecast period. Quaternary ammonium compounds are widely used as surface disinfectants in hospitals and laboratories. These compounds aid in controlling the spread of healthcare-associated infections in hospitals and clinics. In addition, it is also used for disinfecting medical equipment that come into direct contact with skin. Rising incidence of hospital-acquired infections across the globe is likely to positively impact the segment growth. For instance, as per WHO, every year, 7 out of every 100 hospitalized patients in industrialized nations and 10 out of every 100 hospitalized patients in underdeveloped countries acquire at least one healthcare-associated infection.

The enzyme segment is anticipated to witness the fastest growth rate over the forecast period. Generally, enzyme-based antiseptics and disinfectants are used to control odor that are created by chemical processes. It is also commonly used in research facilities for cleaning enzyme-based or catalyst-based products. It's used to clean testing kits in hospitals and clinics. The demand for these items is predicted to rise as the number of research facilities grows as a result of increased R&D spending around the world. For instance, as per Congressional Research Service, globally, total global R&D spending has more than tripled in current dollars since 2000, rising from $677 billion to $2.2 trillion in 2019, which is expected to boost the number of research laboratories owing to which segment is anticipated to grow over the forecast period.

Product Insights

Medical device disinfectants segment held the largest market in 2022 with around 45.7%. Medical device disinfectants are generally used for reprocessing of surgical units and endoscopes. Glutaraldehyde, phenol/phenate, hydrogen peroxide, and peracetic acid are some of the disinfectants used for reprocessing/disinfection of medical devices. Proper reprocessing of medical devices and endoscopes are essential as they transmit infection from one patient to another due to direct contact with skin. Increasing number of surgical procedures across the globe may be considered to be one of the major reasons for driving the segment over the forecast period.

The enzymatic cleaners segment is anticipated to witness the fastest growth rate over the forecast period. Enzymatic cleansers are more efficient on bacterial surfaces and are commonly used to avoid odor. It's commonly used to disinfect testing kits and surgical equipment in clinics and hospitals. The number of surgical procedures and the amount of hospital-acquired illnesses are two important variables driving the industry. Non-pathogenic beneficial microorganisms in enzyme cleaners are effective at displacing disease-causing germs without causing any side effects. The residue of certain antiseptics and disinfectants can sometimes cause harm to humans. In such cases, enzymatic cleaners are used. Hence, the segment is anticipated to grow over the forecast period.

Sales Channel Insights

B2B segment held the largest market share in 2022 with around 65.00%. In B2B sales channel, companies directly sell their products to businesses and not to consumers. B2B sales channel usually have longer sales cycle and higher order values. B2B sales channel is expected to witness a low growth rate during the forecast period owing to entry barriers in the B2B business, which includes lack of investment to develop technologically advanced products and challenges pertaining to coordinating with various vendors. Medical device disinfectants, enzymatic cleaners, and surface disinfectants are major antiseptics & disinfectants marketed under the B2B sales channel. Hospitals, clinics, healthcare providers, and suppliers are major end users of the B2B sales channel.

The FMCG distribution channel comprises three major entities: agents, facilitators, and merchants. Agents generally generate sales by promoting products of the company. Agents can be a member of the company or an independent individual. Facilitators are generally involved in the transportation of manufactured goods from one place to another. Warehouse owners, logistic services, and independent type are included under the facilitator’s category. Wholesalers and retailers are generally categorized under the merchant’s category. Consumers generally purchase FMCG products directly from retailers and wholesalers. Hand sanitizers, antiseptic topical creams, antiseptic washes, and antiseptics wipes are categorized under the FMCG product line. 3M, Lifebuoy, Dettol, and Purell are some of the notable brands of hand sanitizers. Nufree Finipil Pro Elec Antiseptic Cream, Tea Tree Therapy Antiseptic Cream, and Neosporin are some of the notable antiseptics topical cream brands marketed as FMCG products.

End-use Insights

Hospital segment dominated the market with the share of 46.40% in 2022, Increasing incidence of hospital-acquired infections across the globe is one of the major reasons for segment growth over the forecast period. For instance, as per CDC, every day, around 1 out of every 31 hospital patients contracts a hospital-acquired infection. The use of appropriate disinfectants and antiseptics is critical in reducing the spread of illnesses. Furthermore, increasing healthcare expenditure in developed and developing countries might increase the number of hospitals owing to which demand for antiseptics & disinfectants is also expected to increase. For instance, as per Eurostat, Germany, and France, had the highest healthcare expenditure (around 11.8%) in GDP in 2019. Thus, such factors are expected to propel the segment growth over the forecast period.

Over the forecast period, the increasing number of surgical procedures and hospitals will be important drivers to the segment's growth. To maintain a healthy atmosphere in the clinic, basic sanitation and hygiene are required. Additionally, an increase in the number of hospital-acquired infections may increase demand for antiseptics and disinfectants. Therefore, the segment is expected to grow over the forecast period.

Regional Insights

North America dominated the antiseptics & disinfectants market in 2022 with around 34.39%. The growing number of healthcare personnel conducted in North America, as well as increasing number of surgeries, are predicted to increase demand for disinfectants and antiseptics in the region. Antiseptic and disinfectant solutions are necessary for surgical procedures and research because they limit the danger of contamination and infection transmission from one patient to the next. Furthermore, as doctors encourage the use of disinfection treatments, an increase in the number of hospital-acquired illnesses may drive up demand for such solutions. As a result, these factors are projected to drive market expansion throughout the forecast period.

Increasing incidence of healthcare-associated infections, food poisoning, cholera, and typhoid fever is a major factor driving the market over the forecast period. In addition, rising awareness about home cleanliness among people is likely to positively impact the market growth. Furthermore, major players are also making efforts to enter into untapped markets in Asia Pacific region, thereby expanding the market scope.

Key Companies & Market Share Insights

Key players are involved in adopting strategies such as merger & acquisitions, partnership and launching new products to strengthen their foothold in the antiseptics & disinfectants market.

Key players are entering into mergers & acquisitions to increase its market share and customer base across the globe. For instance, in January 2021, Cantel Medical Corporation was acquired by STERIS through a subsidiary in the U.S. Cantel is a global provider of infection prevention services and products, with a focus on dental and endoscopic customers. Thus, this in turn is projected to boost the market growth.

Moreover, in June 2018, Fortive Corporation has made a binding bid to buy Johnson & Johnson's Advanced Sterilization Products business, which is part of Ethicon, Inc. The antiseptics and disinfectants market is dominated by the following companies. Some prominent players in the global antiseptic and disinfectant market include:

• 3M

• Reckitt Benckiser

• Steris Plc

• Kimberly-Clark Corporation

• Bio-Cide International, Inc.

• Cardinal Health

• BD

• Johnson & Johnson

Antiseptic And Disinfectant Market Report Scope

Global Antiseptic And Disinfectant Market Report Segmentation

This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2018 to 2030. For the purpose of this study, Grand View Research has segmented the global antiseptic and disinfectant market report on the basis of type, product, sales channel, end use, and region:

• Type Outlook (Revenue USD Million, 2018 - 2030)

  • Quaternary Ammonium Compounds

  • Chlorine Compounds

  • Alcohols & Aldehyde Products

  • Enzyme

  • Others

• Product Outlook (Revenue, USD Million, 2018 - 2030)

  • Enzymatic Cleaners

  • Medical Device Disinfectants

  • Surface Disinfectants

• Sales Channel Outlook (Revenue, USD Million, 2018 - 2030)

  • B2B

  • FMCG

• End Use Outlook (Revenue, USD Million, 2018 - 2030)

  • Hospitals

  • Clinics

  • Others

• Regional Outlook (Revenue, USD Million, 2018 - 2030)

  • North America

    • U.S.

    • Canada

  • Europe

    • U.K.

    • Germany

    • France

    • Italy

    • Spain

  • Asia Pacific

    • Japan

    • China

    • India

    • Australia

    • South Korea

  • Latin America

    • Brazil

    • Mexico

    • Argentina

    • Colombia

  • Middle East and Africa (MEA)

    • South Africa

    • Saudi Arabia

    • UAE